Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Fresenius Medical Care AG (FMCQF) over the last 13 years, with Q2 2025 value amounting to $5.6 billion.

  • Fresenius Medical Care AG's Other Accumulated Expenses rose 152.31% to $5.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $5.6 billion, marking a year-over-year increase of 152.31%. This contributed to the annual value of $5.1 billion for FY2024, which is 1170.96% down from last year.
  • As of Q2 2025, Fresenius Medical Care AG's Other Accumulated Expenses stood at $5.6 billion, which was up 152.31% from $4.9 billion recorded in Q1 2025.
  • Fresenius Medical Care AG's Other Accumulated Expenses' 5-year high stood at $6.0 billion during Q1 2024, with a 5-year trough of $4.9 billion in Q1 2025.
  • Over the past 3 years, Fresenius Medical Care AG's median Other Accumulated Expenses value was $5.6 billion (recorded in 2024), while the average stood at $5.5 billion.
  • The largest annual percentage gain for Fresenius Medical Care AG's Other Accumulated Expenses in the last 5 years was 152.31% (2025), contrasted with its biggest fall of 1732.91% (2025).
  • Over the past 3 years, Fresenius Medical Care AG's Other Accumulated Expenses (Quarter) stood at $5.8 billion in 2023, then decreased by 11.71% to $5.1 billion in 2024, then rose by 10.83% to $5.6 billion in 2025.
  • Its last three reported values are $5.6 billion in Q2 2025, $4.9 billion for Q1 2025, and $5.1 billion during Q4 2024.